Display Single Record

FOI Request

Disclosure ID
FOI/05268
Request Date
September 8, 2023
Subject
Drugs
Description

I have a Freedom of information query. How many patients has your trust/health board treated in the past 6 months (for any disease) with the following drugs:

-Aubagio (teriflunomide)
-Avonex (interferon beta-1a)
-Betaferon (interferon beta-1b)
-Brabio (glatiramer acetate)
-Copaxone (glatiramer acetate)
-Extavia (beta interferon-1b)
-Gilenya (fingolimod)
-Lemtrada (alemtuzumab)
-Kesimpta (ofatumumab)
-Mavenclad (cladribine)
-Mayzent (siponimod)
-Ocrevus (ocrelizumab)
-Plegridy (peginterferon beta-1a)
-Ponvory (ponesimod)
-Rebif (beta interferon-1a)
-Tecfidera (dimethyl fumarate)
-Tysabri (natalizumab)
-Tysabri (natalizumab) pre-filled syringes ONLY
-Vumerity (diroximel fumarate)
-Zeposia (ozanimod)

Response

I have a Freedom of information query.  How many patients has your trust/health board treated in the past 6 months (for any disease) with the following drugs:

Aubagio (teriflunomide)  0
Avonex (interferon beta-1a)  0
Betaferon (interferon beta-1b)  0
Brabio (glatiramer acetate)  0
Copaxone (glatiramer acetate)   0
Extavia (beta interferon-1b)   0
Gilenya (fingolimod)   0
Lemtrada (alemtuzumab)   0
Kesimpta (ofatumumab) 0
Mavenclad (cladribine)  <5*
Mayzent (siponimod) 0
Ocrevus (ocrelizumab)  0
Plegridy (peginterferon beta-1a) 0
Ponvory (ponesimod) 0
Rebif (beta interferon-1a)   0
Tecfidera (dimethyl fumarate)   <5*
Tysabri (natalizumab)  0
Tysabri (natalizumab)  pre-filled syringes ONLY 0
Vumerity (diroximel fumarate) 0
Zeposia (ozanimod) 0

*The requested information relates to a very small number of individuals and to provide further detail could potentially lead to identification. This would breach their confidentiality; therefore we are exempting this information as personal and applying Section 40(2).

Attachment 1
Attachment 2
Attachment 3
Attachment 4
Attachment 5
Attachment 6
Attachment 7
Attachment 8
Attachment 9